Table 1 Characteristics of study patients and corresponding relatives in families with more than one childhood cancer (FAM > 1)
From: Predominance of girls with cancer in families with multiple childhood cancer cases
Study patient | Relative of study patient | ||||||
|---|---|---|---|---|---|---|---|
Nr | Diagnosis | Gender | Age (years) | Diagnosis | Gender | Age (years) | Degree of relative |
Leukemia | |||||||
1 | ALL | m | 4.3 | ALL | m | 4.2 | 5 |
ALL | f | 3.9 | 5 | ||||
2 | ALL | f | 2.1 | ALL | f | 5.6 | 5 |
ALL | f | 7.5 | 5 | ||||
3 | ALL | f | 6.0 | ALL | f | 14.1 | 3 |
4 | ALL | f | 4.4 | ALL | f | 5.3 | 1 |
5 | ALL | f | 2.3 | ALL | f | 1.3 | 4 |
6 | ALL | f | 3.2 | Leukemiaa | f | 13.0 | 2 |
7 | ALL | f | 8.1 | AML | m | 17.7 | 2 |
8 | ALL | f | 3.4 | Hodgkin lymphoma | m | 10.5 | 4 |
9 | ALL | f | 2.1 | Ganglioglioma | m | 7.0 | 1 |
10 | ALL | f | 8.6 | Ewing sarcoma | f | 8.2 | 5 |
11 | ALL | f | 1.6 | Retinoblastoma | f | 2.1 | 3 |
12 | AML | f | 12.4 | ALL | f | 4.5 | 4 |
13 | AML | f | 2.3 | AML | m | 0.3 | 4 |
CNS tumors | |||||||
14 | Ependymoma | m | 11.7 | High grade glioma | f | 5.1 | 3 |
15 | Ependymoma | m | 6.8 | High grade glioma | f | 5.1 | 4 |
16 | Ependymoma | f | 10.2 | CNS tumora | f | 13.1 | 2 |
17 | Astrocytoma | m | 1.6 | Neuroblastoma | f | 0.9 | 1 |
18 | Astrocytoma | f | 16.0 | CNS undefined | f | 7.1 | 5 |
19 | Astrocytoma | f | 14.0 | Hodgkins lymphoma | f | 14.2 | 3 |
20 | Optic tract glioma | f | 4.6 | Ependymoma | f | 0.8 | 4 |
21 | Optic tract glioma | m | 2.2 | Wilms tumor | f | 1.6 | 6 |
22 | Ganglioglioma | f | 14.9 | Astrocytoma | m | 14.5 | 2 |
23 | Adenoma hypophysis | f | 12.8 | Neuroblastoma | m | 2.6 | 3 |
Lymphomas | |||||||
24 | Hodgkin lymphoma | m | 8.3 | ALL | f | 5.6 | 4 |
25 | Hodgkin lymphoma | m | 13.5 | ALL | f | 4 | |
26 | Hodgkin lymphoma | f | 15.3 | Wilms Tumor | f | 13.2 | 3 |
Ewing sarcoma | m | 13.2 | 3 | ||||
27 | Hodgkin lymphoma | f | 17.0 | CNS tumora | m | 0.0 | 3 |
28 | Burkitt lymphoma | m | 14.5 | Astrocytoma | f | 0.9 | 5 |
29 | Burkitt lymphoma | m | 16.1 | Rhabdomyosarcoma | m | 9.1 | 2 |
30 | Anaplastic large cell lymphoma | m | 12.9 | Hepatoblastoma | m | 0.9 | 5 |
31 | Diffuse large B-cell lymphoma | m | 16.5 | AML | m | 8.0 | 3 |
Other diagnoses | |||||||
32 | Hepatoblastoma | f | 2.6 | Hodgkin lymphoma | m | 11.7 | 3 |
33 | Langerhans cell histiocytosis | m | 4.3 | Langerhans cell histiocytosis | m | 2.7 | 1 |
34 | Wilms tumor | m | 3.5 | ALL | m | 5.3 | 2 |
35 | Neuroblastoma | f | 0.3 | CNS tumora | f | 9.8 | 6 |
36 | Ganglioneuroblastoma | f | 2.7 | Osteosarcoma | f | 19.0 | 2 |
37 | Rhabdomyosarcoma | m | 2.2 | CNS tumora | f | 6.0 | 5 |
Malign melanomaa | f | 17.5 | 4 | ||||
38 | Rhabdomyosarcoma | m | 4.4 | Astrocytoma | f | 3.9 | 5 |
39 | Retinoblastoma | f | 0.4 | Retinoblastom | m | 0.3 | 1 |
40 | Hepatoblastoma | f | 2.5 | Leukemiaa | m | <19b | 4 |
41 | Dysgerminoma | f | 12.6 | Leukemiaa | f | 5.0 | 4 |